Haloperidol and Nalbuphine: Interaction Details
- Haloperidol
- Haldol
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Haloperidol and Nalbuphine interaction:
Nalbuphine
We don't have a drug information page for Nalbuphine yet. Have a question about Nalbuphine? Ask a pharmacist, free →
What Happens When You Take Haloperidol With Nalbuphine
What can happen when they are taken together (rated Major)
Increased risk of respiratory and
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Between 2004 and 2011, emergency department visits tied to non-medical use of together with analgesics rose significantly, and deaths from drug overdose involving both drug classes climbed as well. Over the same period, the share of opioid overdose deaths in which benzodiazepines were also implicated grew.
One study found that overdose deaths among patients who had been dispensed both an opioid and a benzodiazepine were 10 times higher than among those dispensed an opioid only. A separate Veterans Health Administration study showed that patients on opioids who had either a past or a current benzodiazepine prescription faced a higher risk of overdose death than patients on opioids with no benzodiazepine prescription history, and that this risk rose as the daily benzodiazepine dose rose.2
Nalbuphine should be used together with depressants only in patients for whom alternative options are inadequate. When combined use cannot be avoided, the lowest effective dose and the shortest duration needed to reach treatment goals should be used. A lower dose of either nalbuphine or the CNS depressant may be considered, along with close monitoring for and .1
The Haloperidol and Nalbuphine Interaction, Explained
Taking haloperidol with nalbuphine can make you extra sleepy and slow your breathing. Haloperidol (Haldol) is an that can cause drowsiness. Nalbuphine is an pain medicine that can also cause sleepiness and slow breathing. Together, these effects can add up. The warning is based on how these kinds of medicines work together, rather than on a study of these two drugs specifically, but it is taken seriously because slowed breathing can be dangerous.
Keep taking your medicines as prescribed and talk with your pharmacist or doctor about this combination. Your care team can manage it by adjusting doses and watching you more closely for sleepiness or slow breathing. Get urgent help if you are very hard to wake or breathing seems weak.
and () between haloperidol (D2 with sedative effects) and nalbuphine (mixed kappa /mu partial agonist ). Neither drug's is the mechanism, and no activation issue changes the direction. Onset is unspecified. Evidence is theoretical; the supporting data are extrapolated from opioid and co-use (higher overdose mortality), not from this pair.
- Reserve co-use for patients in whom alternatives are inadequate.
- Use the lowest effective dose and shortest duration.
- Consider reducing the dose of nalbuphine or the other CNS depressant.
- Monitor closely for and respiratory depression.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Haloperidol and Nalbuphine Interact
The likely mechanism
How to Manage the Haloperidol and Nalbuphine Interaction
Your care team may choose to use this combination only if other options are not adequate for you. If you need both, they will typically aim for the lowest doses and the shortest time that works, and the dose of one or both medicines may need to be adjusted and individualized by your care team. Your team may monitor you more closely for sleepiness and slowed breathing.
- Keep taking both medicines exactly as prescribed.
- Tell your pharmacist or prescriber about any other sedating medicines or alcohol.
- Report unusual drowsiness, confusion, or slow or shallow breathing right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Haloperidol or Nalbuphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning
Between 2004 and 2011, the rate of emergency department visits related to non-medical use of together with analgesics rose significantly, from 11 visits per 100,000 population to 34.2 visits per 100,000 population. Drug overdose deaths involving both benzodiazepines and opioid analgesics (covering doses as prescribed as well as doses exceeding those prescribed) also rose, from 0.6 per 100,000 population to 1.7 per 100,000 population. The share of opioid overdose deaths in which benzodiazepines were also implicated grew from 18% to 31%2
-
Report 2 · Study title
Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning
In a prospective cohort study conducted in North Carolina, the rate of overdose death among patients dispensed both and was 10 times that among patients dispensed opioids alone (7 per 10,000 person-years vs 0.7 per 10,000 person-years). A case-cohort study in the Veterans Health Administration showed that patients receiving opioids who had a history of benzodiazepine prescriptions or a current benzodiazepine prescription faced a higher risk of overdose death than patients receiving opioids with no history of benzodiazepine prescription, with the risk rising 2.33- to 3.86-fold in patients with current or past benzodiazepine prescriptions. Higher daily benzodiazepine doses were also associated with a greater risk of death from drug overdose2
Haloperidol and Nalbuphine: Common Questions
How serious is the Haloperidol and Nalbuphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Haloperidol and Nalbuphine interaction managed?
Your care team may choose to use this combination only if other options are not adequate for you. If you need both, they will typically aim for the lowest doses and the shortest time that works, and the dose of one or both medicines may need to be adjusted and individualized by your care team. Your team may monitor you more closely for sleepiness and slowed breathing. Keep taking both medicines ex… Management is individual — always follow your own care team's guidance.
Is there an alternative to taking Haloperidol with Nalbuphine?
The interaction record says a different medicine may be considered in place of one of these two.
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Haloperidol and Nalbuphine Interaction
Ask in your own words about taking Haloperidol and Nalbuphine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: NUBAIN(R) intramuscular, subcutaneous, intravenous injection, nalbuphine HCl intramuscular, subcutaneous, intravenous injection. Par Pharmaceutical (per FDA), Chestnut Ridge, NY, 2016.
- US Food and Drug Administration (FDA): Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. US Food and Drug Administration (FDA). Silver Spring, MD. 2016.
Other Serious Interactions of Haloperidol and Nalbuphine
Also serious with Haloperidol
- Ketoconazole TopicalContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
- DronedaroneContraindicated
Also serious with Nalbuphine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Haloperidol
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Indian SnakerootMajor
- + 208 more
With Nalbuphine
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- L-TryptophanMajor
- AshwagandhaModerate
- + 92 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.